Chris Gugl

Chris Gugl has a diverse work experience in the healthcare and digital health industry. Chris is currently the CEO of Evoleen, a company focused on making digital healthcare accessible. In addition, they hold the position of Lecturer in MAS digital Clinical Research at ETH Zurich.

Chris has also been involved in various startup ventures, serving as a Co-Founder and Executive Board Member in companies such as Albatross Care, Therayou, WINGS Health, Carity, and SIVA Health. These startups specialize in areas such as psychocardiological monitoring, respiratory diagnostics, and therapy compliance.

Prior to their entrepreneurial pursuits, Chris worked as the Head of Integrated Care at Helbling Technik AG. During their time there, they contributed to the development of integrated care solutions.

Furthermore, Chris has provided advisory services for PharmaBiome AG, a pre-clinical microbiome company.

Overall, Chris Gugl's work experience demonstrates their commitment to driving innovation and improving healthcare outcomes through digital solutions and interdisciplinary collaboration.

Chris Gugl completed their Executive MBA from the University of St.Gallen in 2017. Prior to that, they pursued a Master of Science (MSc) in Biomedizintechnik/Medizintechnik at ETH Zürich. No specific start and end years were provided for their studies at ETH Zürich.